10% OFF SITEWIDE

00h00m00s
use codeAUGUST10stacks on top of bundle savings
side-by-side research comparison

Cagrilintide vs GLP-3 RTA

Cagrilintide and GLP-3 RTA are both studied in weight research, but they are different classes of compound with different reported research applications.

✓ both US-made · third-party tested · batch COA on every order

at a glance

CagrilintideGLP-3 RTA
compound classLong-acting amylin analog peptideSynthetic triple-agonist peptide
research areaweight & metabolicweight & metabolic
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
price from$172.49$155.99
availabilityout of stockin stock

what each one is

Cagrilintide

Long-acting amylin analog peptide

Cagrilintide is a synthetic long-acting analog of amylin, the pancreatic peptide co-secreted with insulin from beta cells. Its sequence is engineered for solubility and resistance to aggregation, and it carries a fatty-acid side chain that extends circulating half-life in pre-clinical systems, giving researchers a stable tool compound where native amylin is notoriously difficult to work with.

full Cagrilintide profile →

GLP-3 RTA

Synthetic triple-agonist peptide

GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.

full GLP-3 RTA profile →

where the research differs

Both compounds are supplied strictly for laboratory research use only. Reported research contexts for each:

Cagrilintide

  • Amylin- and calcitonin-receptor agonism research
  • Calcitonin-receptor / RAMP complex pharmacology studies
  • Peptide aggregation, solubility, and stability research
  • Metabolic-signaling research models
  • Comparative studies alongside incretin-receptor reference compounds

GLP-3 RTA

  • GLP-1, GIP, and glucagon receptor agonism research
  • cAMP and class B GPCR signaling research models
  • Comparative single-, dual-, and triple-agonist pharmacology studies
  • Metabolic-pathway and nutrient-handling research models
  • Peptide half-life, lipidation, and stability research

shop either compound

Cagrilintidecurrently out of stock
GLP-3 RTAfrom $155.99

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

build a stack with both →

frequently asked

What is Cagrilintide?

Cagrilintide is a synthetic long-acting analog of the pancreatic peptide amylin, engineered for stability and extended half-life. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is Cagrilintide studied for in research?

It is used as a reference agonist in amylin- and calcitonin-receptor pharmacology, RAMP-complex research, and metabolic-signaling models in vitro and pre-clinically. Verve makes no health claims.

What is GLP-3 RTA?

GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is GLP-3 RTA studied for in research?

In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.